Effects of very low-fat diets on anginal symptoms.
Michael
M
Sweeney
D000083:Acetanilides; D000787:Angina Pectoris / Q000150:complications / Q000503:physiopathology / Q000517:prevention & control*; D002331:Carnitine / Q000627:therapeutic use; D017024:Chemotherapy, Adjuvant / Q000379:methods; D048909:Diabetes Complications / Q000503:physiopathology / Q000517:prevention & control; D003920:Diabetes Mellitus / Q000503:physiopathology / Q000517:prevention & control*; D018752:Diet, Fat-Restricted / Q000379:methods*; D014676:Diet, Vegetarian; D004730:Endothelium, Vascular / Q000187:drug effects / Q000503:physiopathology; D004791:Enzyme Inhibitors / Q000627:therapeutic use; D005227:Fatty Acids / Q000378:metabolism; D006321:Heart / Q000294:innervation / Q000503:physiopathology; D006801:Humans; D010879:Piperazines / Q000008:administration & dosage* / Q000009:adverse effects / Q000627:therapeutic use; D016032:Randomized Controlled Trials as Topic; D000069458:Ranolazine; D016896:Treatment Outcome
D000083:Acetanilides; D004791:Enzyme Inhibitors; D005227:Fatty Acids; D010879:Piperazines; D000069458:Ranolazine; D002331:Carnitine